ASKA Pharmaceutical Holdings Co., Ltd.

4886・Prime Market・Pharmaceuticals

Official website

ASKA Pharmaceutical Holdings Co., Ltd.

4886・Prime Market・Pharmaceuticals

Official website

ASKA Pharmaceutical Holdings Co., Ltd.4886

Reference Indicators

Market Cap

639¥100M

P/E (Forecast)

13.1x

P/B

0.9x

Dividend Yield (Forecast)

2.92%

ROE

8.0%

EV/EBITDA

7.3x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	56,607	60,461	62,843	64,139	71,127
Cost of Sales	30,255	31,876	32,178	32,803	36,982
Gross Profit	26,351	28,584	30,664	31,335	34,145
SG&A Expenses	21,556	23,476	24,164	26,003	28,311
Operating Income	4,795	5,108	6,500	5,331	5,834
Non-operating Income	379	433	414	398	740
Non-operating Expenses	294	308	392	622	908
Ordinary Income	4,880	5,232	6,522	5,107	5,665
Extraordinary Income	9,683	124	3,340	1,384	1,570
Extraordinary Losses	8,400	—	—	300	244
Pre-tax Income	6,163	5,357	9,862	6,192	6,991
Income Taxes	1,873	1,118	2,316	1,091	1,366
Net Income	4,290	4,238	7,545	5,101	5,424
EBITDA	7,680	8,235	9,162	7,578	8,919
Gross Margin	46.6%	47.3%	48.8%	48.9%	48.0%
Operating Margin	8.5%	8.4%	10.3%	8.3%	8.2%
ROA	5.2%	4.9%	8.3%	5.1%	4.8%
ROE	8.8%	8.2%	13.0%	8.0%	8.0%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
医薬品事業	58,927	7,121	12.1%
アニマルヘルス事業	7,334	344	4.7%
海外事業	4,640	108	2.3%
その他	225	-13	-5.8%